FlexiLingo
Will the AI labs eat everything or is tech just too sure of itself to tell what actually lasts? This week, Compound's Michael Dempsey explains why he invests against the herd in a market running on FOMO. We explore which SaaS companies survive AI, why sentiment has turned against tech, his case for a historic decade in bio, and why crypto venture went quiet while onchain assets got interesting. Enjoy! TIMESTAMPS: 00:00 Intro 01:29 How Do You Invest Without FOMO? 08:30...
No transcript for this episode yet
You can still listen to it in the player. On episodes with a transcript, you can tap any word to see its meaning.